BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 36279987)

  • 1. Shoulder arthroplasty device clearance: an ancestral network analysis.
    Zhu A; Ying X; Carey EG; Pean CA; Premkumar A; Fu MC; Taylor SA
    J Shoulder Elbow Surg; 2023 Mar; 32(3):671-676. PubMed ID: 36279987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Interconnected Ancestral Network of Hip Arthroplasty Device Approval.
    Premkumar A; Zhu A; Ying X; Pean CA; Sheth NP; Cross MB; Gonzalez Della Valle A
    J Am Acad Orthop Surg; 2021 Dec; 29(24):e1362-e1369. PubMed ID: 34161960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Complex Process of Using the Interconnected Knee Arthroplasty Device Clearance Pathway.
    Zhu A; Ying X; Pean CA; Sheth NP; Cross MB; Gonzalez Della Valle A; Premkumar A
    HSS J; 2022 Nov; 18(4):462-468. PubMed ID: 36258781
    [No Abstract]   [Full Text] [Related]  

  • 4. Mapping the genealogy of medical device predicates in the United States.
    Pai DB
    PLoS One; 2021; 16(10):e0258153. PubMed ID: 34618861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Orbital Implants Receiving Food and Drug Administration Premarket Notification.
    Corcoran Ruiz KM; Vaishnav YJ; Desautels J; Schaefer JL; Migliori ME; Yilmaz T
    Ophthalmic Plast Reconstr Surg; 2022 Sep-Oct 01; 38(5):503-506. PubMed ID: 35699217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association Between Regulatory Submission Characteristics and Recalls of Medical Devices Receiving 510(k) Clearance.
    Everhart AO; Sen S; Stern AD; Zhu Y; Karaca-Mandic P
    JAMA; 2023 Jan; 329(2):144-156. PubMed ID: 36625811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of Recalled Devices in New Device Authorizations Under the US Food and Drug Administration's 510(k) Pathway and Risk of Subsequent Recalls.
    Kadakia KT; Dhruva SS; Caraballo C; Ross JS; Krumholz HM
    JAMA; 2023 Jan; 329(2):136-143. PubMed ID: 36625810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The regulatory ancestral network of surgical meshes.
    Zargar N; Carr A
    PLoS One; 2018; 13(6):e0197883. PubMed ID: 29920525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How do Orthopaedic Devices Change After Their Initial FDA Premarket Approval?
    Samuel AM; Rathi VK; Grauer JN; Ross JS
    Clin Orthop Relat Res; 2016 Apr; 474(4):1053-68. PubMed ID: 26584802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medical device recalls and the FDA approval process.
    Zuckerman DM; Brown P; Nissen SE
    Arch Intern Med; 2011 Jun; 171(11):1006-11. PubMed ID: 21321283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Research: Evaluation of Orthopedic Hip Device Recalls by the FDA from 2007 to 2017.
    Peters W; Pellerin C; Janney C
    Biomed Instrum Technol; 2020 Nov; 54(6):418-426. PubMed ID: 33339030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recall Rates of Total Knee Arthroplasty Devices Are Dependent on the FDA Approval Process.
    Pellerin C; Adamson M; Janney C
    Cureus; 2020 Aug; 12(8):e9744. PubMed ID: 32944459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of Recall Among Medical Devices Undergoing US Food and Drug Administration 510(k) Clearance and Premarket Approval, 2008-2017.
    Dubin JR; Simon SD; Norrell K; Perera J; Gowen J; Cil A
    JAMA Netw Open; 2021 May; 4(5):e217274. PubMed ID: 33956132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recalls of Moderate- and High-Risk Otolaryngologic Devices Approved by the US Food and Drug Administration, 2003-2019.
    Talati IA; Parsa KM; Gao WZ
    Otolaryngol Head Neck Surg; 2022 Nov; 167(5):832-838. PubMed ID: 35290135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of FDA-Approved Orthopaedic Devices and Their Recalls.
    Day CS; Park DJ; Rozenshteyn FS; Owusu-Sarpong N; Gonzalez A
    J Bone Joint Surg Am; 2016 Mar; 98(6):517-24. PubMed ID: 26984921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dermatologic Device Clearance Within the Food and Drug Administration's 510(k) Pathway.
    Ezaldein HH; Hill ST; Merati M; Suggs A; Reichert B; Scott JF
    Lasers Surg Med; 2020 Nov; 52(9):837-841. PubMed ID: 32221981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. US Food and Drug Administration Clearance of Moderate-Risk Otolaryngologic Devices via the 510(k) Process, 1997-2016.
    Rathi VK; Gadkaree SK; Ross JS; Kozin ED; Sethi RK; Naunheim MR; Puram SV; Gray ST
    Otolaryngol Head Neck Surg; 2017 Oct; 157(4):608-617. PubMed ID: 28786317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incremental Revisions across the Life Span of Ophthalmic Devices after Initial Food and Drug Administration Premarket Approval, 1979-2015.
    Gopal AD; Rathi VK; Teng CC; Del Priore L; Ross JS
    Ophthalmology; 2017 Aug; 124(8):1237-1246. PubMed ID: 28501378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FDA-cleared artificial intelligence and machine learning-based medical devices and their 510(k) predicate networks.
    Muehlematter UJ; Bluethgen C; Vokinger KN
    Lancet Digit Health; 2023 Sep; 5(9):e618-e626. PubMed ID: 37625896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medical devices: US medical device regulation.
    Jarow JP; Baxley JH
    Urol Oncol; 2015 Mar; 33(3):128-32. PubMed ID: 25458071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.